Latest news Image by Marco Verch. Creative Commons licence.The Liver Meeting 2021: CoronavirusPeople with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines. The Liver Meeting 2021: Hepatitis C eliminationHepatitis C treatment in US declined from 2015 to 2020. PexelsThe Liver Meeting 2021: CoronavirusTreatment for hepatitis B and C fell in 2020 due to COVID-19, global survey finds. infohep news COVID-19 vaccine protection is ‘lower and slower’ in people with cirrhosis Keith Alcorn / 22 November 2021 People with cirrhosis of the liver take longer to achieve protection from severe COVID-19 after vaccination and remain at higher risk of hospitalisation, according to large studies in the United States and ... Coronavirus People with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines Keith Alcorn / 16 November 2021 People with cirrhosis of the liver had delayed and suboptimal responses to the Pfizer or Moderna SARS-CoV-2 vaccines compared to healthy adults, an Italian study has found. People with decompensated cirrhosis had significantly ... View all infohep news Editors' picks from other sources ERN Rare Liver statement on SARS-CoV-2 booster vaccinations European Reference Network on Hepatological Diseases / 11 November 2021 Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access Treatment Action Group / 04 November 2021 Australia: Sustained investment is needed to eliminate hepatitis C by 2030 Burnet Institute / 04 November 2021 View all news from other sources Conference news More conference news Noticeboard ILC 2016 webinar: watch again More noticeboard posts Email updates Sign up for our monthly bulletins Sign up today Other pages in this section Latest news All the news Conference news Noticeboard Email bulletins News feeds